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Abstract Protein kinase CK2 is a heteromeric enzyme with
catalytic (K) and regulatory (L) subunits which form an K2L2
holoenzyme and utilizes both ATP and GTP as nucleotide
substrate. Site-directed mutagenesis of CK2K subunit was used
to study this capacity to use GTP. Deletion of asparagine 118
(KvN118) or the mutant KN118E gives a 5^6-fold increase in
apparent Km for GTP with little effect on the affinity for ATP.
Mutants KN118A and KD120N did not alter significantly the Km
for either nucleotide. CK2KvN118 has an apparent Ki for inosine
5P triphosphate 5-fold higher than wild-type and is very heat
labile. These studies complement recent crystallographic data
indicating a role for CK2K asparagine 118 in binding the guanine
base.
z 2000 Federation of European Biochemical Societies.
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1. Introduction
Protein kinase CK2 is a pleiotropic and ubiquitous enzyme
that phosphorylates a large number of protein substrates.
Abundant evidence indicates that this enzyme plays an impor-
tant role in the regulation of gene expression and cell division
(reviews [1^3]).
Protein kinase CK2 is normally found as a heterotetramer
that contains catalytic (K and KP) and regulatory (L) subunits
which are present in K2L2, KKPL2 and K2L2 combinations. The
sequences of the catalytic subunits are highly conserved in a
wide range of eukaryotic species and contain the typical 12
regions that are common to the large superfamily of protein
kinase [4]. Considerable e¡ort has been made in several labo-
ratories to study the structure and function of both subunits
[5^7]. Recently, important advances in the elucidation of this
problem have been made through the solution of the crystal
structure of the Zea mays CK2K subunit [8] and a truncated
form of the human CK2L subunit [9].
One of the special characteristics of this protein kinase is
the fact that it can e⁄ciently use GTP, as well as ATP, as a
phosphoryl donor. The crystal form of the Z. mays CK2K
subunit contained one molecule of bound ATP. Unfortu-
nately, the nucleotide triphosphate was partially disordered
so that a de¢nite picture of the binding of the purine base
was not apparent [8]. This information would be highly rele-
vant to answer the question as to the structural features that
allow the CK2K subunit to use GTP as e⁄ciently as ATP.
In an alternative approach, we reported [10]a a structural
computer model of the CK2K structure based on the known
structure of the cyclin-regulated protein kinase CDK2, the
closest relative to CK2 in the protein kinase family. This
approach allowed us to attempt to answer the question as
to the lack of discrimination between the two purine nucleo-
side triphosphates [10]. In that work, it was concluded that a
region involving Asn118 could be in close contact with the
purine base, an idea that was strengthened by the fact that
this asparagine is part of the sequence N117NTD120 that
closely resembles the NKXD conserved sequence present in
G proteins and other GTPases and that is known to partic-
ipate in the recognition of the guanine base [11,12]. Deletion
of Asn118 resulted in a signi¢cant increase in the apparent Km
for GTP and a smaller change in the apparent Km for ATP
[10].
In this report, a comparative study of this and other muta-
tions that substitute for Asn118 is presented, demonstrating
that this amino acid is involved in determining the speci¢city
for the purine base of the phosphoryl donor. In addition, it is
demonstrated that deletion of Asn118 greatly a¡ects the stabil-
ity of the enzyme.
2. Materials and methods
2.1. Materials
[Q-32P]ATP and GTP were obtained from NEN Life Science Prod-
ucts and dephospho-Lcasein, protease inhibitors, nucleotides inosine
5P triphosphate (ITP), XTP and GTP were obtained from Sigma.
NTA-agarose was from Invitrogen. Nucleotide sequencing was per-
formed using a 377 ABI automatic sequencer and oligonucleotides
were synthesized by an ABI DNA synthesizer in the Oligopeptido
Core Facility of the University of Chile.
2.2. Mutants of protein kinase CK2K subunit
The deletion mutant CK2KvN118 was generated by overlapping
primer extension PCR [13] using clones of CK2K in vector pT7-7
[14,15]. The initial ampli¢cation reactions to generate the two over-
lapping fragments used oligonucleotide pairs (5P-TTCGAACATGT-
CAACACAGATTTTAA-3P) and the T7 primer (5P-AATACGACT-
CACTATAG-3P), and for the second fragment (5P-TTAAAAAT-
CTGTGTTGACATGTTCGAA-3P) with the reverse T7 primer (5P-
ATTGGTAACTGTCAGACCAAG-3P).
In the ¢nal ampli¢cation reaction, the T7 and reverse T7 primers
were used with the mixture of the products of the ¢rst two PCR
reactions. The products were digested with NdeI and SalI and sub-
cloned into pT7-7H6 which contains a six histidine tag to facilitate the
puri¢cation [15].
Mutants N118A, N118E and D120N were prepared as given for
vN118 using the same T7 primers and the appropriate oligonucleo-
tides for the initial overlap extension PCR reactions were as follows:
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mutant N118A: 5P-AACATGTCAACGCTACAGATT-3P and 5P-
AATCTGTTAGCGTTGACATGTT-3P, mutant N118E: 5P-AAC-
ATGTCAACGAAACAGATT-3P and 5P-AATCTGTTTCGTTGA-
CATGTT-3P, mutant D120N: 5P-CAACAATACAAATTTTAAG-
CAGT-3P and 5P-ACTGCTTAAAATTTGTATTGTTG-3P.
To generate the double mutation vN118,D120N, mutant vN118
was used as template with the following primers: 5P-GTCAA-
CACAAATTTTAAGCAG-3P and 5P-CTGCTTAAAATTTGTGTT-
GAC-3P with a similar procedure as given above. In all cases, the
complete nucleotide sequence of each recombinant clone was con-
¢rmed by sequencing using a 377 ABI automatic sequencer.
2.3. Preparation of mutant CK2K recombinant proteins
The wild-type and mutant CK2K were cloned in vector pT7-7H6
and expressed in Escherichia coli strain BL21-DE3 after induction at
37‡ with 1 mM IPTG as previously described [15]. The bacterial pellet
was lysed in 1/10 of the volume of the culture in a bu¡er containing 50
mM sodium phosphate bu¡er pH 8.0, 300 mM NaCl, 10 mM imida-
zole, 20 mM L-mercaptoethanol and 0.5% Triton. In addition, the
bu¡er contained a mixture of protease inhibitors including 4 Wg/ml
of pepstatin, leupeptin and antipain, 5 Wg/ml of aprotinin and 1 mM
PMSF. Immediately after lysis, recombinant CK2L subunit, prepared
as described previously [15], was added (8 nmol per l of culture) to
stabilize the activity of the mutant CK2K preparations. After centri-
fugation of the extract for 30 min at 6000Ug, the His-tagged proteins
were puri¢ed from the soluble fraction using a Ni-NTA-agarose
column as indicated by the manufacturer. The eluted fractions were
analyzed for their catalytic activity and the presence of proteins of the
expected molecular mass by sodium dodecyl sulfate gel electrophore-
sis.
2.4. Protein kinase CK2 assay
The standard assay mixture contained in a ¢nal volume of 30 Wl : 50
mM HEPES, pH 7.7, 100 mM NaCl, 10 mM MgCl2 0.5 mM dithio-
threitol, 10 mg/ml dephospho-Lcasein and 50 WM of either [Q-32P]ATP
(1300 cmp/pmol) or [Q-32P]GTP (2000 counts per min (cpm)/pmol).
5 pmol of CK2K wild-type or mutant K subunits was used per assay
and, in the case of the wild-type enzyme, an equimolar amount of
recombinant CK2L [15] was added to the preparation to give maximal
stimulation of the basal activity of CK2K (usually 6^8-fold stimula-
tion). The maximal stimulation by CK2L was con¢rmed by titration
of the catalytic activity to assure the presence of the heterotetrameric
K2L2 form. In the case of the recombinant CK2K mutants, the CK2L
subunit was added during the preparation of the expressed protein, as
described above. Reactions were carried out for 10 min at 30‡C and
terminated by the absorption of an aliquot to Whatman P81 paper,
followed by washing three times in 75 mM phosphoric acid. Results
are expressed as pmol of [32P]phosphate incorporated into protein
substrate per min.
Initial velocity measurements for determination of the apparent Km
were performed under the standard conditions except for the varied
nucleotide substrate concentrations (ATP or GTP, 10^500 WM) and
varying the radiolabel between 400 and 10 000 cmp/pmol. Controls
were performed in the absence of enzyme for each level of radioac-
tivity. Apparent Km values were determined from Lineweaver^Burk
double reciprocal analysis and using the program Microcal Origin 2.8.
Ki values were obtained from the slopes observed at the di¡erent
inhibitor concentrations. All reactions were performed in duplicate
and the data represent results obtained from 3^5 individual experi-
ments.
3. Results
Mutants of recombinant CK2K subunit were prepared as
indicated in Section 2. Due to the extreme thermal lability of
the mutant in which the asparagine 118 has been deleted, the
regulatory L subunit of CK2, which in a great measure sta-
bilizes the enzyme, was added immediately after lysis to all the
bacterial extracts that expressed the K subunit mutants. After
puri¢cation of the recombinant reconstituted holoenzymes
through Ni-NTA-agarose that retains the histidine-tagged
proteins, their apparent Km values for ATP and GTP were
determined.
As had been shown previously [10], the deletion of Asn118
(CK2KvN118) causes an important increase in the apparent Km
for GTP but a considerably lower increment in the Km value
for ATP (Table 1). The mutation of Asn118 to alanine
(CK2KN118A) does not a¡ect the a⁄nity for either nucleotide.
Similarly, the mutation of Asp120 to asparagine (CK2KD120N)
does not a¡ect signi¢cantly the Km values. On the other hand,
the mutation of the Asn118 to glutamic acid (CD2KN118E)
causes a 6-fold increment in the Km for GTP without a¡ect-
ing at all the apparent Km for ATP. The double mutant with
deleted Asn118 and mutated Asp120 to Asn (CK2KvN118;D120N)
has properties very similar to the single deletion of Asn118.
The di¡erent a⁄nities of the CK2KvN118 for the nucleoside
triphosphates were also studied through competition experi-
ments using purine nucleoside triphosphates. Fig. 1 shows the
inhibition of the CK2 activity by the presence of non-radio-
active GTP, when [Q-32P]ATP is used as substrate. It is clearly
observed that GTP is a weaker inhibitor when the CK2KvN118
is used as compared to the wild-type, con¢rming the lower
a⁄nity of this mutant for GTP.
Kinetic studies on the inhibition by ITP of both the wild-
type and the CK2KvN118 mutant using GTP as a substrate
(Fig. 2) demonstrated that ITP, as expected, is a competitive
inhibitor. These experiments allowed us to calculate the ap-
Table 1
Apparent Km values for substrates ATP and GTP of reconstituted
holoenzyme protein kinase CK2 and holoenzymes formed from sev-
eral CK2K mutants
CK2K subunit Km ATP (WM) Km GTP (WM)
KWT 19 þ 3 30 þ 5
KvN118 49 þ 2 149 þ 3
KN118A 16 þ 3 39 þ 1
KN118E 20 þ 4 199 þ 4
KD120N 22 þ 1 54 þ 0.3
KvN118;D120N 41 þ 3 158 þ 7
The formation of the mutant holoenzymes and assay conditions are
given in Section 2.
Fig. 1. Inhibition by the alternate nucleotide substrate GTP of re-
combinant wild-type protein kinase CK2K2L2 holoenzyme and hol-
oenzyme formed from CK2KvN118 and CK2L. Using the standard
assay described in Section 2 and 50 WM [Q-32P]ATP as labeled nu-
cleotide substrate, activities of wild-type (F) and vN118 mutant
holoenzyme (a) were measured in the presence of varying levels of
unlabeled GTP. The 100% values of incorporation of [32P]phosphate
into substrate casein were 48 pmol per min for wild-type enzyme
and 17 pmol per min for the mutant.
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parent Ki for ITP which for the wild-type is 75 WM, while for
the CK2KvN118, it is 360 WM. Similar experiments using XTP
as inhibitor showed that CK2KvN118 activity is likewise less
a¡ected than wild-type enzyme by this purine analogue (not
shown).
Our previous observation as to the extreme lability of
CK2KvN118 led us to study the e¡ect of exposing the holoen-
zymes of these mutants to preincubation at 45‡C. Fig. 3 shows
that, while the CK2KN118A, CK2KN118E mutants behave very
much as the wild-type enzyme, the CK2KvN118 is much more
labile, reaching complete inactivation after 10 min at this tem-
perature.
4. Discussion
The results presented here extend our previous observations
that indicated that Asn118 is involved in determining the un-
usual nucleotide speci¢city of protein kinase CK2 [10]. The
function of this amino acid residue was examined considering
that a computational model of CK2K constructed on the basis
of the tridimensional structure indicated that Asn118 might be
in close proximity to the nucleotide base. Additional interest
was suggested by the fact that this residue is part of a se-
quence (N117NTD120) which is analogous to the NKXD se-
quence that has been shown to play a critical role in the
speci¢city for GTP of G proteins and other known GTPases
[11,12]. The hypothesis that this sequence plays a similar role
in CK2 as it does in G proteins has been discarded by the
experiments presented above. In G proteins and in GTPases,
such as protein synthesis elongation factors and transducin,
the aspartic acid that is part of that sequence plays a key role
in stabilizing the guanine moiety through hydrogen bonding
with the N1 nitrogen and the amino group in ring position 2.
The change of aspartic acid to asparagine drastically modi¢es
the nucleotide speci¢city of these proteins [11]. On the other
hand, in the present case, mutation of the equivalent Asp120 to
Asn in CK2K did not a¡ect its a⁄nity for GTP or ATP and
the double mutant CK2KvN118;D120N has speci¢city properties
similar to that of the CK2vN118 single mutant.
The observation that the CK2KN118A behaves as the wild-
type suggests that the Asn side chain may not be playing a
major role for GTP usage, whereas the observation that the
CK2KN118E behaves as the deletion mutant that eliminates
Asn118 in selectively lowering the a⁄nity for GTP indicates
that an acidic side chain in that position can disturb the
function that the backbone of Asn118 may play in GTP rec-
ognition.
Not surprisingly, the lower a⁄nity of CK2KvN118 for GTP
extends to other purine nucleotides, in particular ITP. The
Asn118 deletion raises the apparent Ki for ITP from 75 WM
to 360 WM.
It is interesting that the CK2KvN118 and CK2KN118E which
have similar properties with regard to nucleotide speci¢city,
but they di¡er markedly in their response to heat treatment.
Thus the deletion of Asn118 causes a dramatic labilization of
the enzyme while the substitution of asparagine for glutamic
acid gives a protein with heat stability similar to the wild-type.
In the computational model, Asn118 appears as an ‘insertion
segment’ that changes the local structure of the nucleotide
pocket when compared to other protein kinases [10]. This
apparent distortion would seem to be important in maintain-
ing the stability of the native enzyme.
Fig. 2. Comparison of the inhibition of recombinant holoenzyme
K2L2 protein kinase CK2K2L2and holoenzyme formed from
CK2KvN118 and CK2L by the substrate analog ITP. Double recipro-
cal plots of 1/velocity vs. 1/GTP concentration. Substrate [Q-32P]-
GTP, between 10 and 125 WM, was used as variable substrate in the
otherwise standard conditions given in Section 2. A: Wild-type
holoenzyme assayed without additions (F) or with 100 (b) or 200
(R) WM ITP. B: Holoenzyme formed from CK2KvN118 and assayed
without additions (F) or with 150 (b) or 300 (R) WM ITP.
Fig. 3. Heat inactivation of recombinant wild-type holoenzyme pro-
tein kinase CK2K2L2 and holoenzyme prepared using mutant CK2K
subunits. Wild-type holoenzyme CK2K2L2 (F) or mutant KvN118 (a),
KN118A (R) or KN118E (P) were preincubated for di¡erent time
periods at 45‡C and assayed using 500 WM substrate GTP (133
cpm/pmol) and otherwise standard conditions as given in Section 2.
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When this manuscript was in preparation, a publication by
Nie¢nd et al. appeared [16]. This work is crucial to our under-
standing of the nucleotide speci¢city of CK2K since it solved
the crystal structure of the K subunit bound to non-hydro-
lyzable analogues of ATP and GTP in the presence of Mg2.
This work demonstrates that CK2 uses both purine bases by
allowing a displacement of the position of the guanine base
relative to the adenine position along the backbone of the
enzyme and that water molecules play key roles in the ¢t of
the guanine base.
Relevant to the work presented here, the results of Nie¢nd
et al. [16] demonstrate that Asn118 is hydrogen-bonded
through its backbone nitrogen to the backbone carbonyl of
valine 16, a link that is especially important for binding of the
guanine base and which is not present in other kinases. In
addition, it is found that the side chain of Asn118 is linked
to the ribose-2PO of GTP through a water molecule. Our
results on the involvement of Asn118 in the determination of
the nucleotide speci¢city and the e⁄ciency of GTP usage by
holoenzyme CK2 complement and are fully in accord with the
crystallographic data.
There has been some debate as to the physiological meaning
of this almost unique capacity of CK2 to use e⁄ciently GTP
as a phosphoryl donor. Although this matter has not been
resolved, the availability of mutants such as CK2KvN118 and
CK2KN118E which are almost normal for ATP usage but have
a much lower a⁄nity for GTP could be very useful in trying
to address this question.
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